| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating activities: | ||||||||
Net income (loss) | ||||||||
4,686 | 8,212 | 10,257 | 10,642 | 11,249 | 13,015 | 0 | 0 | 0 |
Adjustments for: | ||||||||
Depreciation of property, equipment and intangibles | ||||||||
35,749 | 35,009 | 34,312 | 33,965 | 32,934 | 31,486 | 0 | 0 | 0 |
Stock-based compensation | ||||||||
1,065 | 976 | 1,024 | 1,037 | 0 | - | 0 | 0 | - |
Stock-based compensation | ||||||||
- | - | - | - | - | - | - | - | 0 |
Unrealized foreign exchange | ||||||||
-8 | -8 | -36 | 9 | 13 | 4 | 0 | 0 | 0 |
Deferred income tax recovery | ||||||||
-2,827 | -3,440 | -2,972 | -2,813 | -2,881 | -2,407 | 0 | 0 | 0 |
Change in fair value of contingent consideration | ||||||||
1,269 | 2,861 | 3,506 | 3,997 | 2,537 | 971 | 0 | 0 | 0 |
Accretion on contingent consideration and deferred consideration | ||||||||
90 | 133 | 166 | 191 | 174 | 166 | 0 | 0 | 0 |
Amortization of deferred financing fees | ||||||||
301 | 276 | 260 | 260 | 260 | 260 | 0 | 0 | 0 |
(Gain) loss from equity investment | ||||||||
1,626 | 1,766 | 0 | 0 | 0 | - | - | - | - |
Change in current tax receivable | ||||||||
0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
Change in trade and other receivables | ||||||||
-4,015 | -1,376 | 2,303 | 3,278 | 4,967 | 3,981 | 0 | 0 | 0 |
Change in prepaid expenses | ||||||||
246 | -132 | -120 | -236 | -441 | -171 | 0 | 0 | 0 |
Change in inventories | ||||||||
-307 | -53 | -213 | 117 | 142 | -20 | 0 | 0 | 0 |
Change in trade and other payables | ||||||||
-1,358 | 121 | -652 | 1,519 | 1,296 | 101 | 0 | 0 | 0 |
Change in employee benefits | ||||||||
222 | 110 | 230 | 320 | 300 | 326 | 0 | 0 | 0 |
Net cash provided by operating activities | ||||||||
40,414 | 45,005 | 43,813 | 45,014 | 42,085 | 40,992 | 0 | 0 | 0 |
Financing activities | ||||||||
Repayment of member loans | ||||||||
- | - | 0 | - | 0 | - | 0 | - | 0 |
Proceeds (repayment) of member loans | ||||||||
- | - | - | 0 | - | - | - | 0 | - |
Equity investment loan | ||||||||
- | - | - | 0 | 0 | - | - | - | - |
Proceeds from short-term advances | ||||||||
- | - | - | - | 0 | - | 0 | - | - |
Payment of deferred consideration | ||||||||
0 | - | - | 0 | - | - | - | 0 | - |
Repayment of short-term advances | ||||||||
- | - | - | 0 | - | - | - | - | - |
Payment of contingent consideration | ||||||||
- | - | - | 0 | - | - | - | - | - |
Repayment of notes payable and bank indebtedness | ||||||||
0 | - | 0 | - | 0 | - | - | - | - |
Proceeds from bank indebtedness | ||||||||
0 | - | - | - | - | - | - | - | - |
Repayment of notes payable and bank indebtedness | ||||||||
- | - | - | 0 | - | - | - | 0 | 0 |
Proceeds on bank indebtedness | ||||||||
- | - | 0 | 0 | - | 22,800 | 0 | 0 | 0 |
Payment of deferred financing fees | ||||||||
0 | - | - | - | - | - | - | - | - |
Proceeds from exercise of stock options | ||||||||
- | - | 0 | 0 | - | - | - | - | - |
Distributions to non-controlling interest | ||||||||
14,020 | 15,825 | 16,475 | 17,009 | 16,550 | 19,289 | 0 | 0 | 0 |
Repurchase of shares for cancellation | ||||||||
-3,377 | -4,742 | -6,154 | -5,609 | -4,740 | -3,774 | 0 | 0 | 0 |
Net cash used in financing activities | ||||||||
-17,191 | -27,793 | -28,804 | -25,735 | -17,895 | -15,873 | 0 | 0 | 0 |
Investing activities | ||||||||
Acquisition of property and equipment | ||||||||
30 | 59 | 71 | 69 | 60 | 35 | 0 | 0 | 0 |
Deferred asset acquisition costs | ||||||||
194 | 59 | 0 | 0 | 0 | - | - | - | - |
Acquisition of equity interest from non-controlling interest | ||||||||
- | - | 0 | 0 | - | - | - | - | - |
Acquisition of anesthesia services providers | ||||||||
- | 15,052 | 11,460 | 18,561 | 23,253 | 27,509 | 0 | 0 | 0 |
Distribution received from equity investment | ||||||||
- | - | 0 | - | - | - | - | - | - |
Purchase adjustment relating to anesthesia service providers acquired in prior periods | ||||||||
- | - | 0 | - | - | - | - | - | - |
Net cash used in investing activities | ||||||||
-15,459 | -20,592 | -16,623 | -21,201 | -23,453 | -27,660 | 0 | 0 | 0 |
Effects of foreign exchange on cash and cash equivalents | ||||||||
-6 | 2 | -3 | 14 | 1 | 2 | 0 | 0 | 0 |
Increase (decrease) in cash and cash equivalents | ||||||||
7,757 | -3,378 | -1,617 | -1,907 | 737 | -2,539 | 0 | 0 | 0 |
Supplemental disclosures: | ||||||||
Cash interest paid | ||||||||
2,777 | 3,055 | 3,671 | 3,499 | 3,396 | 3,180 | 0 | 0 | 0 |
Non-cash acquisition financing | ||||||||
- | - | 0 | - | - | - | - | - | - |
Taxes paid | ||||||||
4,557 | 4,127 | 4,593 | 4,915 | 6,698 | 7,055 | 0 | 0 | 0 |
Operating lease payments | ||||||||
346 | 369 | 351 | 332 | 0 | - | 0 | 0 | - |
Non-cash acquisition costs | ||||||||
- | - | - | - | 0 | - | - | - | - |